Myeloma Paper of the Day, December 14th, suggested by Robert Orlowski – OncoDaily
Myeloma Paper of the Day, December 14th, suggested by Robert Orlowski / Andri Olafsson, Ásbjörn Jónsson, Bjarni Agnarsson, Brynjar Viðarsson, cancer, Edith
Myeloma Paper of the Day, December 14th, suggested by Robert Orlowski / Andri Olafsson, Ásbjörn Jónsson, Bjarni Agnarsson, Brynjar Viðarsson, cancer, Edith
Nature – Complete blood count indices are tightly regulated around setpoints for decades in healthy adults, and represent a deep phenotype providing opportunities for investigating…
I’ll teach you how to become the media’s go-to expert in your field. Enroll in The Professional’s Media Academy now: https://www.professionalsmediaacademy.co…
The BBC speaks to men released from Saydnaya prison – a place known as the “human slaughterhouse”.
PURPOSESWOG S1815 was a randomized, open label phase III trial, evaluating gemcitabine, nab-paclitaxel, and cisplatin (GAP) versus gemcitabine and cisplatin (GC) in patients with newly…
With more than 150 treatments being studied in clinical trials, what is on the horizon for antibody-drug conjugates in breast cancer?
PURPOSESWOG S1815 was a randomized, open label phase III trial, evaluating gemcitabine, nab-paclitaxel, and cisplatin (GAP) versus gemcitabine and cisplatin (GC) in patients with newly…
Previously, addition of isatuximab (Isa) to standard-of-care lenalidomide-bortezomib-dexamethasone (RVd) in transplant-eligible patients with newly diagnosed multiple myeloma in the GMMG-HD7 trial (ClinicalTrials.gov identifier: NCT03617731) resulted…
Reinstate Martin Kulsdorf and others fired because of Biden’s COVID-19 vaccine mandate
This study examines the impact of cytogenetic abnormalities and their co-segregation on the prognosis of newly diagnosed multiple myeloma patients. The analysis included 1304 patients…
Assessing the response to systemic therapy in neuroendocrine tumors (NET) is challenging since morphological imaging response is often delayed and not necessarily reflective of clinical…